GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HMGCR, HSD11B1, HSD17B1, HSD17B2, HTR1A, KDR, MET, PPARA, SLC1A1, SLC6A2, SLC6A3, SRC, TRPV1, XDH |
11.9656 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, ALPI, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, FABP3, FABP4, FUT7, HMGCR, HSD11B1, HSD17B1, HSD17B2, MET, PPARA, TRPV1 |
9.93485 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, FABP3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, MMP2, MMP9, NR3C1, PPARA, SLC6A3, SRC, TRPV1, TYR |
9.56605 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, KDR, MMP2, NR3C1, PPARA, SLC6A3, SRC, TRPV1, TYR |
9.56605 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, ALOX12, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, HMGCR, HTR1A, SLC6A3, TYR |
9.1705 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSD17B2, IGF1R, KDR, MMP2, MMP9, NR3C1, PPARA, SLC6A2, SLC6A3, SRC, TRPV1, TYR |
8.95256 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SLC6A3, SRC |
8.55265 |
[BP] GO:0007215 |
None
|
APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.5463 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APEX1, APP, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, FLT3, NR3C1, SLC6A3, SRC, TRPV1, TYR |
6.84021 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, ALOX12, ALOX15, ALOX5, ALPI, APP, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, FABP4, GRM1, GRM5, GRM8, HMGCR, HSD17B2, HTR1A, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC6A2, SLC6A3, SRC, TRPV1, TYR |
6.84021 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, FABP3, HMGCR, KDR, NR3C1, SLC6A2, SLC6A3, SRC, TRPV1 |
6.83341 |
[BP] GO:0007193 |
None
|
DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8, HTR1A |
6.83341 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD2, DRD3, DRD4, HTR1A, SLC6A3, TYR |
6.76325 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, APP, CA2, CA7, DRD2, DRD3, DRD4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.66932 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, APP, CA2, CA7, DRD2, DRD3, DRD4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.66932 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX12, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FUT7, GLO1, HMGCR, PIM1, PPARA, TYR, XDH |
6.59723 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
6.42939 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, HMGCR, KDR, SLC6A3, SRC |
6.39514 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD2, DRD3, DRD4, GRIK5, HTR1A, SLC1A1, SLC6A2, SLC6A3, TRPV1 |
6.31741 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, DRD3, DRD4, FABP3, PPARA, SLC1A1, TRPV1 |
6.22188 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, ALOX12, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, MET, SRC, TRPV1 |
6.1547 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX12, ALOX15, ALOX5, ALPI, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, FABP3, FABP4, FUT7, HMGCR, MET, PPARA |
6.11623 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HMGCR, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, SLC1A1, SLC6A3, SRC, TOP2A, TRPV1, XDH |
6.08718 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, FABP3, FLT3, GRIK5, GRM1, GRM5, HMGCR, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, SRC, TOP2A, TRPV1, XDH |
5.90919 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, DRD2, DRD3, DRD4, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, SLC6A3, SRC, TRPV1, TYR |
5.88761 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX12, ALOX15, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2, TYR, XDH |
5.79356 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA3, ALOX12, ALOX15, APEX1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, GRIK5, GRM5, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, PPARA, SRC, TRPV1 |
5.79356 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, ALOX12, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GLO1, GRIK5, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SRC, TOP2A, TRPV1, XDH |
5.59809 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, FLT3, GRM1, HMGCR, KDR, MET, MMP12, MMP9, SRC, XDH |
5.58601 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, FLT3, GRM1, HMGCR, KDR, MET, MMP12, MMP9, SRC, XDH |
5.56371 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, ALOX12, APP, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, FABP3, FABP4, GRIK5, GRM1, GRM5, MET, TRPV1 |
5.52818 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, DRD2, DRD3, DRD4, FABP3, FLT3, GRM5, IGF1R, MMP2, PPARA, SLC6A3, SRC, TRPV1, TYR |
5.52818 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.51424 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, ALOX12, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GLO1, GRIK5, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, SRC, TOP2A, TRPV1, XDH |
5.48659 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
5.39738 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.25427 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
5.18965 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA3, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HMGCR, HSD17B2, HTR1A, IGF1R, KDR, MMP12, MMP2, MMP9, NR3C1, PPARA, SLC6A2, SLC6A3, SRC, TOP2A, TRPV1, TYR |
5.18965 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, DRD3, DRD4, FABP3, PPARA, SLC1A1, TRPV1 |
5.13563 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX12, ALOX15, ALPI, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
5.09187 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX12, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
5.09187 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA3, AKR1B1, ALOX12, APP, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, FABP3, FLT3, HMGCR, HTR1A, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, SRC, XDH |
5.06249 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, MMP9, NR3C1, SRC, TRPV1 |
5.03035 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
5.00057 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, ALOX12, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GLO1, GRIK5, HMGCR, IGF1R, KDR, MMP9, PIM1, SRC, TOP2A, TRPV1, XDH |
4.94745 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, SRC, XDH |
4.91238 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CYP1A1, CYP1B1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, NR3C1, SRC, TRPV1 |
4.89058 |
[BP] GO:0007188 |
None
|
DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8, HTR1A |
4.89058 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
4.84257 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
4.84256 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, SRC, XDH |
4.83496 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX12, ALOX15, CYP19A1, CYP3A4, HMGCR, SLC6A3, TYR |
4.79391 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2 |
4.77025 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APEX1, APP, BCL2, CA2, CSNK2A1, CYP1A2, FABP3, FLT3, GRM5, IGF1R, MMP2, NR3C1, PPARA, SRC, TRPV1 |
4.70325 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9, SLC6A3 |
4.68125 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, HMGCR, HSD11B1, HSD17B1, HSD17B2, HTR1A |
4.68125 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.58483 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, DRD2, DRD3, DRD4, FABP3, GRIA2, GRIA4, GRIK5, PPARA, SLC1A1, SLC6A2, SLC6A3, TRPV1 |
4.55753 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.55723 |
[BP] GO:1900543 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PPARA |
4.54273 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, ALOX12, BCL2, CSNK2A1, DRD2, DRD3, FLT3, HMGCR, HTR1A, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1 |
4.53812 |
[BP] GO:0045980 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PPARA |
4.51594 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, FABP4, GRM3, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, SRC |
4.51594 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.5035 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, CSNK2A1, DRD2, DRD3, DRD4, HTR1A, SLC6A3 |
4.5035 |
[BP] GO:0007187 |
None
|
DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8, HTR1A |
4.49453 |
[BP] GO:0007610 |
None
|
APP, BCL2, DRD2, DRD3, DRD4, GRM1, GRM5, HMGCR, HTR1A, PPARA, SLC6A3, TRPV1 |
4.47706 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
4.40924 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, ALPI, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD11B1, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, SLC6A3, SRC, TOP2A, TRPV1, TYR, XDH |
4.39131 |
[BP] GO:0060078 |
None
|
DRD4, GRIA2, GRIA4, GRIK5, GRM5, TRPV1 |
4.38652 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, FLT3, GRM1, HMGCR, KDR, MET, MMP12, MMP9, SRC, XDH |
4.36731 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
4.23607 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
4.23607 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SRC |
4.20714 |
[BP] GO:0030818 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
4.19723 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DRD3, DRD4, PPARA, SRC, TOP2A |
4.16732 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ALOX15, APP, BCL2, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MMP9, PPARA, SRC, XDH |
4.16207 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, KDR, SRC, TRPV1 |
4.13729 |
[BP] GO:0030803 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
4.12188 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ALOX15, APP, BCL2, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, KDR, MMP9, PPARA, SRC, XDH |
4.12188 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, ALOX15, APP, AXL, BCL2, CYP1B1, DRD2, DRD4, FLT3, GRM1, HMGCR, KDR, MET, SRC, XDH |
4.09732 |
[BP] GO:0007268 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
4.09732 |
[BP] GO:0098916 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
4.09732 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA |
4.05156 |
[BP] GO:0030815 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
4.05041 |
[BP] GO:0099536 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
4.02963 |
[BP] GO:0099537 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
4.02963 |
[BP] GO:1900372 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
4.01923 |
[BP] GO:0030809 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
4.01923 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD2, DRD3, GRM1, HMGCR, MMP2, PPARA, SRC, TRPV1, TYR |
3.98233 |
[BP] GO:0030800 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.98162 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, DRD2, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, MMP9, SRC, TRPV1 |
3.97609 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, SRC |
3.97294 |
[BP] GO:0042391 |
None
|
APP, BCL2, DRD4, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC, TRPV1 |
3.97144 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX12, ALOX15, ALOX5 |
3.95526 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, FLT3, GRM1, HMGCR, IGF1R, KDR, MET, MMP9, SRC, XDH |
3.92805 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1 |
3.92805 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, CYP1B1, GRIK5, GRM5, IGF1R, MMP2, MMP9, NR3C1, SRC, TRPV1 |
3.89589 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA3, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, FABP3, FABP4, GLO1, GRM3, GRM8, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PIM1, PPARA, SLC6A3, SRC, TOP2A, TRPV1, XDH |
3.88132 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA3, AKR1B1, ALOX12, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, FABP3, FABP4, GLO1, GRM3, GRM8, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PIM1, PPARA, SRC, TOP2A, TRPV1, XDH |
3.88132 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA3, ALOX12, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD2, DRD3, IGF1R, KDR, MET, MMP9, SRC |
3.8735 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX12, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1 |
3.85152 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, SLC6A3 |
3.81221 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ALOX15, APP, AXL, BCL2, CA2, CA7, CYP19A1, DRD2, DRD3, DRD4, GRIK5, GRM5, HMGCR, HTR1A, MMP12, MMP9, PPARA, SRC, TRPV1 |
3.80958 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA3, ALOX12, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, SRC |
3.8004 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.79445 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MMP2, MMP9, NR3C1, SRC, TOP2A, TRPV1 |
3.76552 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ALOX12, APP, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, HMGCR, KDR, MET, MMP12, MMP9, PIM1, SLC1A1, SLC6A3, SRC, TRPV1 |
3.7341 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, APEX1, BCL2, CA2, CSNK2A1, CYP1A2, FABP3, FLT3, NR3C1, PPARA, SRC, TRPV1 |
3.72723 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
DRD2, GRM1, GRM3, GRM5, GRM8 |
3.68591 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.68536 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
3.68536 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, FABP3, GRM1, GRM5, TRPV1 |
3.67227 |
[BP] GO:0035235 |
None
|
APP, GRIA2, GRIA4, GRIK5 |
3.67227 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, ALPI, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP2, NR3C1, PIM1, PPARA, SLC6A3, SRC, TOP2A, TYR, XDH |
3.66239 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC |
3.65262 |
[BP] GO:0051940 |
None
|
DRD2, DRD3, DRD4 |
3.59565 |
[BP] GO:0051584 |
None
|
DRD2, DRD3, DRD4 |
3.59565 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, GRM5, IGF1R, PPARA, SRC, TRPV1 |
3.59565 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, PPARA |
3.59565 |
[BP] GO:0007626 |
None
|
APP, DRD2, DRD3, DRD4, GRM1, GRM5, SLC6A3 |
3.59565 |
[BP] GO:0042417 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
3.57145 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA3, ALOX12, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, SRC |
3.55558 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD2, DRD3, SLC6A3 |
3.46799 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
3.46799 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD11B1, HSD17B2, KDR, MET, MMP2, MMP9, PIM1, PPARA, SLC6A3, SRC, TOP2A, TYR |
3.45422 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, FABP4, FLT3, GRM1, HMGCR, KDR, MET, MMP12, MMP2, MMP9, SRC, XDH |
3.43566 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, DRD2, DRD3, HMGCR, KDR, SRC, TRPV1 |
3.42617 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2, SLC6A3 |
3.4142 |
[BP] GO:0033993 |
response to lipid
|
AXL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, NR3C1, SRC, TYR |
3.40389 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, MMP9, PIM1, SRC |
3.40389 |
[BP] GO:0032787 |
None
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PPARA |
3.40389 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.37299 |
[BP] GO:0007194 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.36979 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, NR3C1, SRC, TRPV1 |
3.35244 |
[BP] GO:0007195 |
None
|
DRD2, DRD3, DRD4 |
3.32825 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.32825 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.32825 |
[BP] GO:0031280 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.27837 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC |
3.26614 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD11B1, HSD17B2, KDR, PPARA, SRC, TYR |
3.25273 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA3, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD11B1, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, SLC1A1, SLC6A2, SLC6A3, SRC, TOP2A, TRPV1, XDH |
3.22585 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA3, ALOX12, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD2, IGF1R, KDR, MET, MMP9, SRC |
3.22495 |
[BP] GO:0046717 |
None
|
DRD2, DRD3, DRD4, SLC1A1, TRPV1 |
3.22204 |
[BP] GO:0034776 |
None
|
DRD2, DRD3, DRD4 |
3.20974 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ALOX15, APP, DRD2, DRD4, FLT3, GRM1, HMGCR, KDR, SRC, XDH |
3.19522 |
[BP] GO:0051350 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.19522 |
[BP] GO:0098657 |
import into cell
|
ACHE, ALOX15, APP, AXL, DRD2, DRD3, SLC1A1, SLC6A2, SLC6A3, TRPV1 |
3.16567 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, GRM1, GRM5, TRPV1 |
3.13832 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, GRIK5, GRM1, GRM5, TRPV1 |
3.07343 |
[BP] GO:0019725 |
cellular homeostasis
|
APEX1, APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, GRIK5, GRM1, GRM5, TRPV1 |
3.07343 |
[BP] GO:0022898 |
None
|
APP, BCL2, DRD2, DRD3, DRD4, GRM5, MMP9 |
3.00178 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
3.00178 |
[BP] GO:0060134 |
None
|
DRD2, DRD3, SLC6A3 |
3.00178 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ALOX15, APP, BCL2, DRD2, DRD4, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, SRC, XDH |
2.99119 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ALOX15, APP, BCL2, DRD2, DRD4, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, SRC, XDH |
2.97758 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ALOX15, APP, BCL2, DRD2, DRD4, FABP3, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, SRC, XDH |
2.97758 |
[BP] GO:2001301 |
lipoxin biosynthetic process
|
ALOX12, ALOX15 |
2.96434 |
[BP] GO:2001302 |
lipoxin A4 metabolic process
|
ALOX12, ALOX15 |
2.96434 |
[BP] GO:2001303 |
lipoxin A4 biosynthetic process
|
ALOX12, ALOX15 |
2.96434 |
[BP] GO:0051588 |
None
|
DRD2, DRD3, DRD4, GRIK5, HTR1A |
2.93907 |
[BP] GO:0051580 |
None
|
DRD2, DRD3, DRD4 |
2.92108 |
[BP] GO:0032409 |
None
|
APP, BCL2, DRD2, DRD3, DRD4, GRM5, MMP9 |
2.86325 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, GRM1, GRM5, TRPV1 |
2.85717 |
[BP] GO:0045761 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.85717 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, SLC6A3, SRC, XDH |
2.82975 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, BCL2, CYP1B1, MMP9, SRC |
2.82417 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ALOX15, APP, BCL2, DRD2, DRD4, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, SRC, XDH |
2.82082 |
[BP] GO:0030817 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.78083 |
[BP] GO:0042752 |
None
|
DRD2, DRD3, DRD4, PPARA, TOP2A |
2.78083 |
[BP] GO:0006873 |
cellular ion homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, GRM1, GRM5, TRPV1 |
2.77807 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APEX1, APP, CYP1A1, CYP1B1, FLT3, NR3C1, SRC, TRPV1 |
2.76557 |
[BP] GO:0008542 |
None
|
APP, DRD2, DRD3, HMGCR |
2.76557 |
[BP] GO:0032225 |
None
|
DRD2, DRD3, DRD4 |
2.76557 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX12, ALOX15, ALOX5 |
2.76557 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ALOX15, APP, DRD2, DRD4, FLT3, GRM1, HMGCR, IGF1R, KDR, SRC, XDH |
2.7536 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PIM1, PPARA, TYR |
2.75305 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ALOX15, APP, BCL2, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MMP9, PPARA, SRC, XDH |
2.74628 |
[BP] GO:0045936 |
None
|
DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, HMGCR, IGF1R, PPARA, XDH |
2.71899 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
ALOX12, BCL2, CYP1A1, CYP1A2, CYP1B1 |
2.71752 |
[BP] GO:0010563 |
None
|
DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, HMGCR, IGF1R, PPARA, XDH |
2.71644 |
[BP] GO:0007154 |
None
|
AXL, BCL2, DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2, TRPV1 |
2.71271 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, ALPI, APEX1, APP, AURKB, AXL, BCL2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD11B1, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, SLC6A3, SRC, TOP2A, TRPV1, TYR, XDH |
2.70272 |
[BP] GO:0001504 |
None
|
SLC1A1, SLC6A2, SLC6A3 |
2.69908 |
[BP] GO:0051046 |
None
|
ACHE, CYP19A1, DRD2, DRD3, DRD4, GRIK5, HMGCR, HTR1A, MMP12, SRC, TRPV1 |
2.68199 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPI, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD2, DRD3, DRD4, FLT3, FUT7, GLO1, HMGCR, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SLC6A3, SRC, TOP2A, TYR, XDH |
2.65274 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
MMP1, MMP12, MMP2, MMP9, TRPV1 |
2.64953 |
[BP] GO:0043269 |
regulation of ion transport
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, GRM5, HTR1A, MMP9 |
2.63842 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ALOX15, APP, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PPARA, SRC, TOP2A, TRPV1, XDH |
2.62615 |
[BP] GO:0007632 |
None
|
APP, DRD2, DRD3, HMGCR |
2.62615 |
[BP] GO:0015909 |
None
|
DRD2, DRD3, DRD4, FABP3 |
2.62615 |
[BP] GO:0046942 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA, SLC1A1, TRPV1 |
2.62615 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA3, AKR1B1, ALOX12, ALOX15, ALOX5, ALPI, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, SLC1A1, SLC6A2, SLC6A3, SRC, TOP2A, TRPV1, TYR, XDH |
2.60527 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ALOX15, APP, BCL2, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MMP9, SRC, XDH |
2.60259 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD4, HTR1A, SLC6A2 |
2.60133 |
[BP] GO:0003008 |
None
|
AKR1B1, APP, BCL2, CYP1B1, DRD2, DRD3, GRM1, GRM5, GRM8, HMGCR, HTR1A, SLC6A3, SRC, TRPV1, TYR |
2.5908 |
[BP] GO:0042069 |
None
|
DRD4, HTR1A, SLC6A3 |
2.5908 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.5908 |
[BP] GO:0042053 |
None
|
DRD4, HTR1A, SLC6A3 |
2.5908 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.5908 |
[BP] GO:0051944 |
None
|
DRD2, DRD4 |
2.5908 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.5908 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.5908 |
[BP] GO:0051586 |
None
|
DRD2, DRD4 |
2.5908 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.58772 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, GRM1, GRM5, TRPV1 |
2.58524 |
[BP] GO:0015849 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA, SLC1A1, TRPV1 |
2.58371 |
[BP] GO:0055080 |
cation homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, GRM1, GRM5, TRPV1 |
2.56703 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ALOX12, CYP19A1, DRD2, DRD3, HMGCR, PPARA, SLC6A3 |
2.56703 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.55682 |
[BP] GO:0048148 |
None
|
DRD2, DRD3, DRD4 |
2.53913 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPI, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, DRD2, FLT3, HMGCR, IGF1R, KDR, MET, PIM1, SRC, XDH |
2.53624 |
[BP] GO:0030814 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.52011 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD2, DRD3, HMGCR, TYR |
2.51621 |
[BP] GO:0055074 |
calcium ion homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, GRM1, GRM5, TRPV1 |
2.50413 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.50284 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP3A4 |
2.49619 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, GRM5, IGF1R, MMP2, SRC, TRPV1 |
2.4955 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
AKR1B1, ALOX12, DRD2, MET, TRPV1 |
2.4955 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ALOX12, CYP19A1, DRD2, DRD3, FABP4, HMGCR, KDR, MET, MMP12, PPARA, SLC6A3 |
2.4955 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.49035 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DRD3, HMGCR, IGF1R, MET, MMP9, SRC, XDH |
2.48398 |
[BP] GO:0030802 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.48398 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, GRM1, GRM5, TRPV1 |
2.48097 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, HMGCR, KDR, SRC |
2.48097 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.47469 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.4628 |
[BP] GO:0031279 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.4628 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
APP, CA2, CA7, DRD2, DRD4 |
2.4628 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, FLT3, HTR1A, MET, PIM1, SRC, TYR |
2.45803 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, ALPI, CSNK2A1, DRD2, FABP3, FABP4, MET |
2.4498 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PIM1, PPARA, TYR |
2.44234 |
[BP] GO:0051339 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.44105 |
[BP] GO:0007165 |
signal transduction
|
ADORA3, AKR1B1, APP, AXL, BCL2, CA1, CA2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, IGF1R, KDR, MET, MMP2, MMP9, NR3C1, PIM1, PPARA, SRC, TRPV1 |
2.42986 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, HMGCR |
2.40408 |
[BP] GO:1903963 |
None
|
DRD2, DRD3, DRD4 |
2.39756 |
[BP] GO:0050482 |
None
|
DRD2, DRD3, DRD4 |
2.39756 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.39756 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, APP, AXL, BCL2, CA2, CYP19A1, DRD2, DRD3, DRD4, MMP12, SRC, TRPV1 |
2.38677 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, PIM1, PPARA, TYR |
2.37953 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, APP, GRM5, IGF1R, SRC |
2.37743 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.37442 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, GRM1, GRM5, TRPV1 |
2.36686 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APEX1, APP, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, HMGCR, IGF1R, MET, MMP12, MMP9, NR3C1, PPARA, SRC, TRPV1, XDH |
2.36686 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ALOX15, APP, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, FABP3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PPARA, SRC, TOP2A, TRPV1, XDH |
2.36686 |
[BP] GO:0051582 |
None
|
DRD2, DRD4 |
2.36686 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.36686 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.36476 |
[BP] GO:1900371 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.36414 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.36285 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, MET, SRC, XDH |
2.36232 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.36134 |
[BP] GO:0046683 |
response to organophosphorus
|
APEX1, APP, SLC6A3, TRPV1, TYR |
2.35494 |
[BP] GO:0030808 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.35494 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPI, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, DRD2, FLT3, HMGCR, IGF1R, KDR, MET, PIM1, SRC, XDH |
2.34778 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, CYP19A1, DRD2, DRD3, DRD4, GRIK5, HMGCR, HTR1A, MMP12, SRC |
2.34778 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ALOX12, ALOX15, BCL2, CYP19A1, DRD2, DRD3, HMGCR, IGF1R, MET, MMP12, MMP9, PPARA, SLC6A3, SRC, XDH |
2.34755 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, APP, FLT3, GRM5, IGF1R, MMP2, NR3C1, SRC, TRPV1 |
2.34514 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ALOX15, APP, AURKB, BCL2, DRD2, DRD3, DRD4, FABP3, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PPARA, SRC, TOP2A, TRPV1, XDH |
2.34321 |
[BP] GO:0015718 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
2.33141 |
[BP] GO:0048169 |
None
|
APP, DRD2, GRM5 |
2.32303 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, APP, GRM5, IGF1R, MMP2, SRC, TRPV1 |
2.32252 |
[BP] GO:0042180 |
None
|
AKR1B1, CYP19A1, GLO1, HMGCR |
2.30759 |
[BP] GO:0060079 |
None
|
GRIA2, GRIA4, GRIK5, TRPV1 |
2.30759 |
[BP] GO:0007612 |
None
|
APP, DRD2, DRD3, GRM5, HMGCR |
2.28244 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.28244 |
[BP] GO:0032309 |
None
|
DRD2, DRD3, DRD4 |
2.28244 |
[BP] GO:0001975 |
None
|
DRD2, DRD3, DRD4 |
2.28244 |
[BP] GO:0008306 |
None
|
APP, DRD2, DRD3, HMGCR |
2.26794 |
[BP] GO:0032412 |
None
|
APP, DRD2, DRD3, DRD4, GRM5, MMP9 |
2.26794 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, HMGCR |
2.26122 |
[BP] GO:0034762 |
None
|
APP, BCL2, CA2, DRD2, DRD3, DRD4, GRM5, MMP9 |
2.26122 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, BCL2, DRD2, DRD3, IGF1R, KDR, MET, MMP1, MMP9, SRC |
2.2534 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ALOX12, APP, BCL2, IGF1R, KDR, MET, MMP9, SRC |
2.24365 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GRM5, IGF1R |
2.24365 |
[BP] GO:0030534 |
None
|
APP, DRD2, DRD3, DRD4, PPARA |
2.23594 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.23205 |
[BP] GO:0043271 |
negative regulation of ion transport
|
BCL2, DRD2, DRD3, DRD4, MMP9 |
2.22382 |
[BP] GO:0030799 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.21057 |
[BP] GO:0051122 |
hepoxilin biosynthetic process
|
ALOX12, ALOX15 |
2.19875 |
[BP] GO:0051121 |
hepoxilin metabolic process
|
ALOX12, ALOX15 |
2.19875 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.19875 |
[BP] GO:0032413 |
None
|
DRD2, DRD3, DRD4, MMP9 |
2.19722 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, BCL2, CYP1A1, HMGCR, SLC6A3 |
2.19658 |
[BP] GO:0032845 |
None
|
BCL2, DRD2, HMGCR, SRC, TRPV1 |
2.19287 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9 |
2.1784 |
[BP] GO:1900542 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PPARA |
2.17298 |
[BP] GO:0071715 |
None
|
DRD2, DRD3, DRD4 |
2.17298 |
[BP] GO:1901571 |
None
|
DRD2, DRD3, DRD4 |
2.17298 |
[BP] GO:0014074 |
response to purine-containing compound
|
APEX1, APP, SLC6A3, TRPV1, TYR |
2.17298 |
[BP] GO:0009410 |
None
|
DRD2, DRD3, DRD4, NR3C1, SLC6A3 |
2.17298 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
APEX1, APP, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PPARA, SRC, TRPV1, XDH |
2.17141 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ALOX12, APP, BCL2, IGF1R, KDR, MET, MMP9, SRC |
2.16669 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ALOX15, APP, BCL2, DRD2, DRD4, FLT3, GRM1, GRM5, HMGCR, KDR, MMP9, SRC, XDH |
2.15043 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9 |
2.14987 |
[BP] GO:0046903 |
None
|
ALOX5, APP, AXL, CA2, DRD2, DRD3, DRD4, MMP9, SLC1A1, SLC6A3, TRPV1, XDH |
2.147 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.14589 |
[BP] GO:0043086 |
negative regulation of catalytic activity
|
APP, CSNK2A1, DRD2, DRD3, DRD4, FABP4, GRM3, HMGCR, IGF1R, MMP9, SRC |
2.14493 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA3, AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD4, HTR1A, MMP2, MMP9, PPARA, SLC6A2, SRC, TOP2A, TRPV1 |
2.14238 |
[BP] GO:0002209 |
None
|
BCL2, DRD4, HTR1A |
2.14238 |
[BP] GO:0001662 |
None
|
BCL2, DRD4, HTR1A |
2.14238 |
[BP] GO:1904645 |
response to amyloid-beta
|
APP, GRM5, IGF1R |
2.14238 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CSNK2A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PIM1, PPARA, SLC6A3, SRC, TOP2A, TRPV1, XDH |
2.14224 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FLT3, HSD11B1, HSD17B2, KDR, MMP9, PIM1, PPARA, SLC6A3, SRC, TYR |
2.14202 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.13741 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, FABP4, FLT3, GRM1, HMGCR, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PPARA, SLC6A3, SRC, XDH |
2.13444 |
[BP] GO:0006810 |
None
|
ACHE, ALOX15, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA4, CA7, DRD2, DRD3, DRD4, FABP3, GRIA2, GRIA4, GRIK5, MMP12, MMP9, PPARA, SLC1A1, SLC6A2, SLC6A3, SRC, TRPV1, XDH |
2.12925 |
[BP] GO:0006140 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8, PPARA |
2.12614 |
[BP] GO:0050877 |
None
|
APP, CYP1B1, DRD2, DRD3, GRM1, GRM5, GRM8, HMGCR, SLC6A3, TRPV1, TYR |
2.12308 |
[BP] GO:0042220 |
None
|
DRD2, DRD3, SLC6A3 |
2.11154 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.11154 |
[BP] GO:0006691 |
None
|
ALOX12, ALOX15, ALOX5 |
2.11154 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ALOX12, APP, BCL2, IGF1R, KDR, MET, MMP9, SRC |
2.10811 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.10642 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CYP1B1, GRIK5, HMGCR, MMP9, SRC, TOP2A, TRPV1, XDH |
2.08701 |
[BP] GO:0040018 |
None
|
BCL2, DRD2, SLC6A3 |
2.08459 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, DRD2 |
2.08459 |
[BP] GO:0042596 |
None
|
BCL2, DRD4, HTR1A |
2.08459 |
[BP] GO:0032410 |
None
|
DRD2, DRD3, DRD4, MMP9 |
2.08459 |
[BP] GO:1904063 |
None
|
DRD2, DRD3, DRD4, MMP9 |
2.08459 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.08459 |
[BP] GO:0032415 |
None
|
DRD3, DRD4 |
2.08459 |
[BP] GO:0051934 |
None
|
SLC6A2, SLC6A3 |
2.08459 |
[BP] GO:0021984 |
None
|
DRD2, SLC6A3 |
2.08459 |
[BP] GO:0090494 |
None
|
SLC6A2, SLC6A3 |
2.08459 |
[BP] GO:0090493 |
None
|
SLC6A2, SLC6A3 |
2.08459 |
[BP] GO:0051583 |
None
|
SLC6A2, SLC6A3 |
2.08459 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.08459 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.08459 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HMGCR, HTR1A, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PIM1, PPARA, SLC6A3, SRC, TOP2A, TRPV1, XDH |
2.08032 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CYP1B1, GRIK5, HMGCR, MMP9, SRC, TOP2A, TRPV1, XDH |
2.07542 |
[BP] GO:0051234 |
None
|
ACHE, ALOX15, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA4, CA7, DRD2, DRD3, DRD4, FABP3, GRIA2, GRIA4, GRIK5, MMP12, MMP9, PPARA, SLC1A1, SLC6A2, SLC6A3, SRC, TRPV1, XDH |
2.06067 |
[BP] GO:0006775 |
fat-soluble vitamin metabolic process
|
CBR1, CYP1A1, CYP3A4 |
2.05627 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, GRM1, GRM5, TRPV1 |
2.0489 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CYP1A1, DRD3, FABP3, FLT3, HMGCR, PPARA, SRC |
2.04226 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.03451 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ALOX12, APP, BCL2, IGF1R, KDR, MET, MMP9, SRC |
2.03374 |
[BP] GO:0045927 |
positive regulation of growth
|
ALOX12, BCL2, CSNK2A1, DRD2, PIM1, SLC6A3 |
2.03148 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ALOX15, APP, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, FLT3, GRM1, GRM5, HMGCR, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PPARA, SRC, TOP2A, XDH |
2.02856 |
[BP] GO:0007267 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
2.01978 |
[BP] GO:0042133 |
neurotransmitter metabolic process
|
ACHE, CYP1B1, HTR1A, SLC6A3 |
2.00314 |
[BP] GO:0060359 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
2.00314 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC |
2.00204 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA3, APP, AXL, CA4, DRD2, DRD3, DRD4, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, HTR1A, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3, TRPV1 |
5.67321 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA3, APP, AXL, DRD2, DRD3, DRD4, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, HTR1A, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3, TRPV1 |
5.3304 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA3, ALOX12, ALOX15, ALPI, APP, AXL, CA12, CA14, CA2, CA4, CSNK2A1, DRD2, DRD3, DRD4, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, IGF1R, KDR, MET, MMP2, PIM1, SLC1A1, SLC6A2, SLC6A3, SRC, TRPV1 |
5.13563 |
[CC] GO:0044456 |
None
|
ACHE, APP, DRD2, DRD4, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A3, SRC, TRPV1 |
4.89058 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA3, ALOX12, ALOX15, ALOX5, ALPI, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD11B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MMP2, PIM1, SLC1A1, SLC6A2, SLC6A3, SRC, TRPV1, TYR |
4.89058 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA3, ALOX15, APP, AXL, CA2, CA4, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3, SRC, TRPV1 |
4.66625 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA3, ALOX15, ALPI, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD11B1, HSD17B2, HTR1A, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3, SRC, TRPV1, TYR |
3.8654 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.60387 |
[CC] GO:0098590 |
plasma membrane region
|
CA2, CA4, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, SLC1A1, SRC, TRPV1 |
3.47632 |
[CC] GO:0097060 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, TRPV1 |
3.30823 |
[CC] GO:0043005 |
None
|
APP, CA2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SRC |
3.03681 |
[CC] GO:0098794 |
None
|
APP, DRD2, DRD4, GRIA2, GRIA4, GRM3 |
2.97176 |
[CC] GO:0043197 |
None
|
APP, DRD2, GRIA2, GRIA4, GRM3 |
2.4955 |
[CC] GO:0044309 |
None
|
APP, DRD2, GRIA2, GRIA4, GRM3 |
2.47469 |
[CC] GO:0014069 |
None
|
DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
2.47469 |
[CC] GO:0099572 |
None
|
DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
2.47469 |
[CC] GO:0042995 |
cell projection
|
AKR1B1, APP, CA2, DRD2, DRD3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SRC |
2.14968 |
[CC] GO:0097458 |
None
|
APP, CA2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A2, SLC6A3, SRC, TRPV1 |
2.11732 |
[CC] GO:0031224 |
None
|
ACHE, ADORA3, ALPI, APP, AXL, CA12, CA14, CA4, CYP3A4, DRD2, DRD3, DRD4, FLT3, FUT7, GRIA2, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD11B1, HSD17B2, HTR1A, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3, TRPV1, TYR |
2.06067 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX12, ALOX15, ALOX5, ALPI, APP, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, TYR, XDH |
10.9771 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX12, ALOX15, ALOX5, ALPI, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, FABP3, FABP4, FLT3, GLO1, HMGCR, HSD17B1, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, SLC1A1, SLC6A2, SLC6A3, SRC, TOP2A, TRPV1, TYR, XDH |
9.56605 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.33266 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
8.07739 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX12, ALOX15, ALOX5, ALPI, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, GLO1, HTR1A, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, SLC1A1, SLC6A2, SLC6A3, TOP2A, TRPV1, TYR, XDH |
7.14015 |
[MF] GO:0030594 |
None
|
DRD2, DRD3, DRD4, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HTR1A |
6.92651 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX12, ALOX15, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HMGCR, HSD11B1, HSD17B1, HSD17B2, TYR, XDH |
6.84021 |
[MF] GO:0005506 |
iron ion binding
|
ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
5.8068 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7 |
5.58601 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA3, AXL, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, IGF1R, KDR, MET, NR3C1, PPARA, TRPV1 |
5.47188 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.3304 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SLC6A3, SRC, TOP2A, TRPV1 |
5.31168 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.11046 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, ALPI, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FLT3, FUT7, GLO1, HMGCR, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, SRC, TOP2A, TYR, XDH |
5.09187 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.05752 |
[MF] GO:0004872 |
receptor activity
|
ADORA3, AXL, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, IGF1R, KDR, MET, NR3C1, PPARA, TRPV1 |
4.79391 |
[MF] GO:0046872 |
metal ion binding
|
ALOX12, ALOX15, ALOX5, ALPI, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, SLC1A1, SLC6A2, SLC6A3, TOP2A, TRPV1, TYR, XDH |
4.77181 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA3, AXL, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, IGF1R, KDR, MET, TRPV1 |
4.7707 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA3, AXL, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, IGF1R, KDR, MET, TRPV1 |
4.7707 |
[MF] GO:0035240 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
4.70325 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA3, AXL, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, IGF1R, KDR, MET, NR3C1, PPARA, TRPV1 |
4.62309 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD2, DRD3, DRD4, HTR1A, SLC6A3 |
4.49885 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, GLO1 |
4.48092 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA3, AXL, DRD2, DRD3, DRD4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, IGF1R, KDR, MET, NR3C1, PPARA, TRPV1 |
4.23848 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, CBR1, HMGCR, HSD11B1, HSD17B1, HSD17B2, XDH |
4.21286 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.15929 |
[MF] GO:1901338 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
4.05041 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
3.95526 |
[MF] GO:0008270 |
zinc ion binding
|
ALPI, CA1, CA12, CA2, CA4, CA7, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, PPARA |
3.60387 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.60387 |
[MF] GO:0001591 |
None
|
DRD2, DRD3, DRD4 |
3.59565 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, CBR1, HMGCR, HSD11B1, HSD17B1, HSD17B2 |
3.48382 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.44977 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.338 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.18206 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.17844 |
[MF] GO:0004952 |
None
|
DRD2, DRD3, DRD4 |
3.10161 |
[MF] GO:0047977 |
hepoxilin-epoxide hydrolase activity
|
ALOX12, ALOX15 |
2.96434 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR |
2.93575 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, BCL2, CSNK2A1, DRD2, DRD4, FLT3, GRIK5, HMGCR, IGF1R, KDR, MET, MMP9, TOP2A, TRPV1, TYR, XDH |
2.90649 |
[MF] GO:0005231 |
None
|
GRIA2, GRIA4, GRIK5, TRPV1 |
2.76557 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HMGCR, HSD17B1, SRC, XDH |
2.64063 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.62041 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.5908 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.5908 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.5908 |
[MF] GO:0004052 |
arachidonate 12-lipoxygenase activity
|
ALOX12, ALOX15 |
2.5908 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A3 |
2.5908 |
[MF] GO:0051120 |
hepoxilin A3 synthase activity
|
ALOX12, ALOX15 |
2.5908 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.5908 |
[MF] GO:0099094 |
None
|
GRIA2, GRIA4, GRIK5, TRPV1 |
2.37442 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.36686 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.36686 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.36686 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, APEX1, CSNK2A1, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, SLC6A3, SRC |
2.3225 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX12, ALOX15, ALOX5 |
2.28244 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2 |
2.24365 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX12, ALOX15, ALOX5 |
2.24365 |
[MF] GO:0051721 |
None
|
BCL2, HMGCR, SLC6A3 |
2.20162 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.19875 |
[MF] GO:0005230 |
None
|
GRIA2, GRIA4, GRIK5, TRPV1 |
2.19722 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD17B1, HSD17B2 |
2.17298 |
[MF] GO:0051879 |
Hsp90 protein binding
|
CSNK2A1, KDR, NR3C1 |
2.08459 |
[MF] GO:0005329 |
None
|
SLC6A2, SLC6A3 |
2.08459 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.08459 |
[MF] GO:0042562 |
hormone binding
|
ACHE, HSD17B1, IGF1R, NR3C1 |
2.05103 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP3A4 |
2.02541 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, HMGCR, MET, PPARA, SLC6A3 |
2.00212 |